| |
NewswireToday - /newswire/ -
Santa Monica, CA, United States, 11/14/2006 - Plexus Ventures LLC President, Robert P. Moran has been invited to speak at the 11th Annual Drug Delivery Partnerships conference on the topic of Exubera® and the collaboration between Pfizer and Nektar.
|
| |
Plexus Ventures LLC, a top Pharmaceutical Business Development consultancy based in Philadelphia, PA, announced today that Robert P. Moran, President, has been invited to present at the 11th Annual Drug Delivery Partnerships Conference, January 22-24, 2007 at Red Rock Resort in Las Vegas. Mr. Moran’s presentation, entitled “Exubera®:
The Improbable but Successful Collaboration between Device (Nektar) and Pill (Pfizer) Companies”, will be part of the conference’s Track A: Strategic Business Development for Pharma/Biotech & Drug Delivery Sustainability. Mr. Moran worked as part of the Plexus Ventures LLC team that assisted Nektar in finding a partner for their inhaled insulin technology in 1993.
About Plexus Ventures: Plexus Ventures, founded in 1990, provides strategic advice, business development and alliance management services to clients in the pharmaceutical, biotechnology and drug delivery industries worldwide. Plexus Ventures assists its clients in the areas of in-licensing, out-licensing, acquisitions, divestitures and strategic partnerships. With offices in Frankfurt, London, Los Angeles, Milan, Philadelphia, Tokyo and Warsaw, Plexus Ventures possesses the capabilities to effectively serve clients in the United States, Europe and Asia.
Plexus Ventures is both well-known and well respected by leading research-based pharmaceutical companies worldwide.
|
maryalice_strong[.]plexusventures.com 
